FDA Staff Raises Safety Concerns Over Arthritis Drug Baricitinib
FDA Update: Possible Heart Risks with Clarithromycin; Apadaz Receives FDA Approval
FDA Receives Reports of Loperamide Abuse
U.S. Life Expectancy Fell in 2016 as Opioid Overdoses Surged—CDC
Limbrel Linked to Possible Fatal Adverse Events
Efficacy Studied Following Accelerated Drug Approvals
Flimsy Evidence Behind Many FDA Approvals
DEA Proposes Cutting Production of Come Opioids
Rheumatologists Respond to Prescription Opioid Analgesic Crisis
- 1
- 2
- 3
- …
- 15
- Next Page »